Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.662 USD | -3.72% | +0.05% | -12.28% |
14/05 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
26/04 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.28% | 124M | |
+26.12% | 49.18B | |
+0.77% | 42.11B | |
+49.96% | 40.37B | |
-5.26% | 28.85B | |
+13.31% | 26.09B | |
-22.48% | 18.71B | |
+8.61% | 13.26B | |
+32.25% | 12.32B | |
+0.39% | 11.99B |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals Says No Additional Trials Required to Support Biologics License Application for Lymphir